BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1372247)

  • 1. Distinct modes of transcription read through or terminate at the c-myc attenuator.
    Roberts S; Bentley DL
    EMBO J; 1992 Mar; 11(3):1085-93. PubMed ID: 1372247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct properties of c-myc transcriptional elongation are revealed in Xenopus oocytes and mammalian cells and by template titration, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), and promoter mutagenesis.
    Meulia T; Krumm A; Groudine M
    Mol Cell Biol; 1993 Sep; 13(9):5647-58. PubMed ID: 8355707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protein-binding site in the c-myc promoter functions as a terminator of RNA polymerase II transcription.
    Roberts S; Purton T; Bentley DL
    Genes Dev; 1992 Aug; 6(8):1562-74. PubMed ID: 1644297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription elongation in the human c-myc gene is governed by overall transcription initiation levels in Xenopus oocytes.
    Spencer CA; Kilvert MA
    Mol Cell Biol; 1993 Feb; 13(2):1296-305. PubMed ID: 8423795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid induction of nuclear transcripts and inhibition of intron decay in response to the polymerase II inhibitor DRB.
    Clement JQ; Wilkinson MF
    J Mol Biol; 2000 Jun; 299(5):1179-91. PubMed ID: 10873444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premature termination of transcription from the P1 promoter of the mouse c-myc gene.
    Wright S; Mirels LF; Calayag MC; Bishop JM
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11383-7. PubMed ID: 1763052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA Polymerase II Transcription Attenuation at the Yeast DNA Repair Gene,
    Whalen C; Tuohy C; Tallo T; Kaufman JW; Moore C; Kuehner JN
    G3 (Bethesda); 2018 May; 8(6):2043-2058. PubMed ID: 29686108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo.
    Strobl LJ; Eick D
    EMBO J; 1992 Sep; 11(9):3307-14. PubMed ID: 1505520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequences in the human c-myc P2 promoter affect the elongation and premature termination of transcripts initiated from the upstream P1 promoter.
    Meulia T; Krumm A; Spencer C; Groudine M
    Mol Cell Biol; 1992 Oct; 12(10):4590-600. PubMed ID: 1406649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription-frequency-dependent modulation of an attenuator in a ribosomal protein-RNA polymerase operon requires an upstream site.
    Steward KL; Pierre RS; Linn T
    Microbiology (Reading); 1997 Nov; 143 ( Pt 11)():3501-3511. PubMed ID: 9387228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro analysis of a transcription termination site for RNA polymerase II.
    Wiest DK; Hawley DK
    Mol Cell Biol; 1990 Nov; 10(11):5782-95. PubMed ID: 2233718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional pause, arrest and termination sites for RNA polymerase II in mammalian N- and c-myc genes.
    Keene RG; Mueller A; Landick R; London L
    Nucleic Acids Res; 1999 Aug; 27(15):3173-82. PubMed ID: 10454615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TFIIH functions in regulating transcriptional elongation by RNA polymerase II in Xenopus oocytes.
    Yankulov KY; Pandes M; McCracken S; Bouchard D; Bentley DL
    Mol Cell Biol; 1996 Jul; 16(7):3291-9. PubMed ID: 8668144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro.
    Chodosh LA; Fire A; Samuels M; Sharp PA
    J Biol Chem; 1989 Feb; 264(4):2250-7. PubMed ID: 2914905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription termination factor Pcf11 limits the processivity of Pol II on an HIV provirus to repress gene expression.
    Zhang Z; Klatt A; Henderson AJ; Gilmour DS
    Genes Dev; 2007 Jul; 21(13):1609-14. PubMed ID: 17606639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region.
    Krumm A; Meulia T; Brunvand M; Groudine M
    Genes Dev; 1992 Nov; 6(11):2201-13. PubMed ID: 1427080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable pause positions of RNA polymerase II lie proximal to the c-myc promoter irrespective of transcriptional activity.
    Wolf DA; Strobl LJ; Pullner A; Eick D
    Nucleic Acids Res; 1995 Sep; 23(17):3373-9. PubMed ID: 7567445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of dichloro-beta-D-ribofuranosylbenzimidazole: effect on in vitro transcription.
    Zandomeni R; Mittleman B; Bunick D; Ackerman S; Weinmann R
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3167-70. PubMed ID: 6954467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence requirements for premature termination of transcription in the human c-myc gene.
    Bentley DL; Groudine M
    Cell; 1988 Apr; 53(2):245-56. PubMed ID: 2834065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate, TATA box-dependent polymerase III transcription from promoters of the c-myc gene in injected Xenopus oocytes.
    Bentley DL; Brown WL; Groudine M
    Genes Dev; 1989 Aug; 3(8):1179-89. PubMed ID: 2792759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.